Review Woodburn, K.W., Fan, Q., Winslow, S., Chen, M.J., Mortensen, R.B., Casadevall, N., Stead, R.B. & Schatz, P.J. (2007) Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Experimental Hematology, 35, 1201–1208. Yamada, O., Mizogucji, H. & Oshimi, K. (1997) Cyclophosphamide therapy for pure red cell aplasia associated with granular lymphocyte- proliferative disorders. British Journal of Haematology, 97, 392–399. Young, N.S., Calado, R.T. & Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 2509–2519. Zaentz, S.D., Krantz, S.B. & Brown, E.B. (1976) Studies on pure red cell aplasia. Maintenance therapy with immunosuppressive drugs. Brit- ish Journal of Haematology, 32, 47–54. Zecca, M., Stefano, P., Nobili, B. & Locatelli, F. (2001) Anti-CD20 monoclonal antibody for the treatment of severe, immune-medi- ated, pure red cell aplasia and hemolytic anemia. Blood, 97, 3995– 3997. Zeok, J.V., Todd, E.P., Dillon, M., DeSimone, P. & Utley, J.R. (1979) The role of thymectomy in red cell aplasia. The Annals of Thoracic Surgery, 28, 257–260. 514 ª 2008 The Authors Journal Compilation ª 2008 Blackwell Publishing Ltd, British Journal of Haematology, 142, 505–514